Weight Loss Tablets: Types, Evidence and UK Access

• Sorts every weight loss tablet sold in the UK into four regulatory tiers, because the tier decides whether it works and whether it is legal.
• Answers the speed question honestly, including the review point built into one licensed tablet's own product information.
• Covers the June 2026 change that made a tablet a serious option for the first time.
• Explains what "fat blocker" actually means, and why only one tablet in the UK genuinely does it.

Weight reducing tablets in the UK are not one single type. They include prescription-only medicines, pharmacy medicines, food supplements and products that are unauthorised or illegally marketed. Two products can both be tablets, appear equally professional online and yet be completely different in terms of their legal status, evidence and safety. A licensed medicine has been assessed as part of the UK medicines authorisation process, while a food supplement does not have to demonstrate that it works for weight loss.

This distinction matters because it affects how a product is assessed, who can supply it, who should use it and what you can reasonably expect from it. No licensed weight-loss tablet produces instant weight loss. Some newer oral medicines, including semaglutide and orforglipron, have expanded the options available to people who prefer a tablet rather than an injection

So this page does not give you a ranked list. It explains how weight reducing tablets are classified in the UK, which types are licensed, how effective they are, how quickly they tend to work, who may be eligible, and what to know about options such as orlistat, naltrexone with bupropion, and oral semaglutide. It also covers supplements, illegal products, and safe purchasing, so you can judge what is legal, what is evidence-based, and what to avoid.

Key things to know

• Weight loss tablets in the UK fall into four tiers: prescription only medicines, pharmacy medicines, food supplements, and illegal or unlicensed products.
• Only the first two tiers contain licensed medicines. Everything in tier three is sold without any requirement to prove it works.
• No licensed weight loss tablet works instantly. The realistic timescale is months, and one licensed tablet has a formal review point built into its product information at 16 weeks.
• Only one licensed tablet blocks fat absorption. Everything else marketed as a "fat blocker" or "fat binder" is a supplement, not a medicine.
• The MHRA has seized large quantities of illegal slimming pills containing banned ingredients, many sold as "herbal" or "natural".
• All licensed weight management medicines are used alongside a healthy diet, physical activity, and broader lifestyle changes. Treatment suitability depends on an individual clinical assessment.

On 11 June 2026, the MHRA approved a semaglutide tablet for weight loss and weight management, making it the first oral GLP-1 receptor agonist licensed for this purpose in the UK. In August 2026, the MHRA also authorised orforglipron (Foundayo), another oral GLP-1 medicine for weight management.

The four tiers of weight loss tablet in the UK

Weight-loss tablets encountered by UK consumers generally fall into four broad groups: prescription-only medicines, pharmacy medicines, food supplements, and unauthorised or illegally marketed products. Knowing which category a product belongs to tells you much more about its evidence and regulatory status than an online review or before-and-after photograph.

How do I tell which tier a product is in?

A licensed medicine should have a UK marketing authorisation that can be verified through official medicines information. If a product is being promoted as a medicine but you cannot verify its UK authorisation, treat that as a warning sign.

Traditional herbal medicines are different again and carry a THR number. A THR indicates that the product has met the requirements for that traditional herbal registration route; it does not mean the product has been clinically proven to cause weight loss.

Tier one: prescription only weight loss tablets

Four oral medicines are now licensed in the UK for weight management: orlistat, naltrexone with bupropion, oral semaglutide and orforglipron (Foundayo). They work in different ways, and all prescription treatments are intended to be used alongside appropriate diet and physical activity.

Orlistat: the fat blocker

Orlistat is the longest-established tablet option and the only licensed weight-loss medicine in this group that works by blocking the digestion and absorption of dietary fat. It inhibits enzymes called lipases in the digestive system, so some of the fat you eat is not broken down and instead passes out in the stool. This can also reduce the absorption of fat-soluble vitamins.

The side effects are worth knowing about before treatment starts. Because undigested fat passes through the bowel, particularly fatty meals can cause oily stools, urgency, diarrhoea and other gastrointestinal effects.

That creates a feedback loop no other weight loss medicine has. Orlistat effectively teaches you which meals were high in fat, whether or not you wanted the lesson. Some people find this genuinely useful for changing habits. Others find it intolerable and stop. Both reactions are common and neither is a failure.

Naltrexone with bupropion

This is a fixed combination of two older medicines in a prolonged release tablet, licensed for weight management in adults. It contains the active ingredients naltrexone and bupropion. Naltrexone is an opioid receptor blocker and bupropion affects dopamine and noradrenaline signalling. Together they act on appetite and on the reward value of eating, which is a different target from the fullness signalling that gut hormone medicines use. By acting on appetite and reward pathways, it may reduce cravings, ease food cravings, and curb appetite in people who struggle with reward-driven eating and weight gain.In clinical trials, weight loss varied depending on the study and analysis. Among people who completed 56 weeks of treatment in some trials, average weight loss was around 8.1%, compared with around 1.8% with placebo. These figures should not be treated as a guaranteed result for an individual.

Its contraindication list is broader than most people expect, and this is the main practical point. It is not suitable for people with a history of seizures, uncontrolled high blood pressure, current opioid use or opioid dependence, an eating disorder, or recent use of a type of antidepressant called an MAOI. Bupropion also interacts with a long list of common medicines, including some antidepressants, some heart medicines and tamoxifen. Appetite-focused medicines can also cause psychological effects such as anxiety and insomnia.

That is why a real consultation matters here. A prescriber checks all of this before supply, and a service that does not ask is not doing the job.

Oral semaglutide

In June 2026, the MHRA approved a once-daily semaglutide tablet for weight loss and weight management, making it the first oral GLP-1 receptor agonist licensed for this purpose in the UK. Semaglutide works through GLP-1 signalling, helping regulate appetite and food intake.

The tablet has specific administration requirements. It is taken on an empty stomach with a small amount of water, and patients need to follow the timing instructions provided with the medicine because food and drink can affect absorption.

It contains the same active ingredient as the weekly semaglutide injection, and Wegovy is a weekly injection that reduces appetite by working in the same way through gut-hormone signalling, delivered here as a once daily tablet. Oral semaglutide mimics naturally released hormones to regulate appetite and help reduce appetite. There is a practical catch. It has to be taken on an empty stomach with a small sip of water, with nothing else to eat or drink for a set period afterwards, or absorption drops sharply. Your prescriber and the patient information leaflet will set out the exact timing.

Do not confuse it with the semaglutide tablet licensed for type 2 diabetes, which is a different product with a different licence and different strengths, or with what some people call the wegovy pill as a shorthand.

Tier two: pharmacy medicines

One weight loss medicine is available in the UK without a prescription, but rather than being sold generally over the counter, it is pharmacy-supplied after a suitability check. A lower-strength version of orlistat is available from pharmacies without a prescription. It contains the same active ingredient as prescription-strength orlistat but at a lower dose. The pharmacist should check whether it is suitable for you before supplying it, so that conversation is an important part of the treatment rather than a formality.

Tier three: food supplements

Weight-loss supplements are sold as foods rather than licensed medicines, so they do not go through the same medicine-authorisation process used to establish the quality, safety and effectiveness of licensed medicines.

What about fat binders and fat blockers?

Orlistat is the licensed medicine that reduces dietary-fat absorption by blocking digestive lipases. Products marketed online as “fat binders” may instead contain ingredients such as glucomannan or chitosan. These products should not be described as equivalent to orlistat: they work differently and are sold as supplements rather than licensed medicines.

Some bulk-forming fibre products can increase feelings of fullness, but they should be used according to their product instructions and with sufficient fluid.

Fibre supplements also need to be taken with plenty of fluid. Taken dry or with too little water they can swell and cause a blockage in the throat or gut, which is a recognised risk rather than a theoretical one.

What about stimulants and "metabolism boosting" tablets?

Caffeine, green tea extract, bitter orange and similar ingredients are often marketed as ways to “boost metabolism”. Some may have physiological effects such as increasing alertness or heart rate, but that should not be confused with the clinically meaningful weight loss seen with licensed weight-management medicines. Combining several stimulant-containing products can also increase the risk of unwanted cardiovascular effects.

There is another concern with products bought through unregulated channels: some illegally marketed slimming products have been found to contain undeclared pharmaceutical or stimulant ingredients.

Tier four: illegal and unlicensed tablets

This is the category where claims such as “instant”, “guaranteed” or “rapid” weight loss should make you especially cautious. Legitimate medicines do not promise that everyone will lose a specific amount of weight in a matter of days.

The MHRA has repeatedly taken enforcement action against illegally marketed slimming products. Some products sold as “herbal” or “natural” have been found to contain undeclared pharmaceutical ingredients, while other dangerous substances have also been marketed illegally as weight-loss products.

The problem is not simply that the product may not work. You may not know what is actually in it, how much of the active ingredient it contains, or whether it has been manufactured and stored appropriately.

Red flags on any weight loss tablet listing

• Promises of instant, guaranteed or effortless results.
• No marketing authorisation number and no named registered pharmacy.
• A prescription only medicine offered with no health questions, or questions that cannot be failed.
• Sold through social media, marketplaces or direct messages.
• Before and after photographs presented as proof of a typical outcome.
• Described as "herbal" or "natural" while claiming a strong pharmaceutical effect.

How fast do weight loss tablets actually work?

No licensed weight loss tablet works instantly, and none is designed to. These are treatments measured over months, and the honest framing is not speed but whether treatment is working at all by a defined point.

Is there a "fastest" weight loss tablet?

There is no single “fastest” weight-loss tablet that is right for everyone. Average results differ between medicines, but those averages come from different clinical trials involving different people, doses and study designs.

Some injectable weight-management medicines have produced larger average weight reductions in their respective trials. However, those results should not be treated as a direct head-to-head ranking of tablets versus injections. Treatment choice also depends on your health, other medicines, side effects, preferences and whether the medicine is clinically appropriate for you.

When should you expect to know if it is working?

You should not expect a meaningful result within a few days. Some medicines have a specific point at which treatment is reviewed. For example, the Mysimba product information says treatment should be discontinued after 16 weeks if at least 5% of the person's starting body weight has not been lost.

That illustrates an important principle of weight-management treatment: progress should be reviewed rather than assuming that a medicine will eventually work if you simply keep taking it.

What does the evidence show?

The amount of weight lost in clinical trials varies between medicines, and each figure needs to be understood in the context of its own study.

Naltrexone with bupropion: In the phase 3 programme, average weight loss varied between studies and depended on the analysis used. In one 56-week study, mean weight loss was 5.4% with naltrexone/bupropion compared with 1.3% with placebo. Among participants who completed treatment, the corresponding figure was 8.1% versus 1.8%.

Oral semaglutide: In OASIS 4, oral semaglutide produced substantial average weight loss over 64 weeks. The trial results should be presented separately from injectable semaglutide because they were different studies.

Orlistat: Orlistat generally produces a more modest average weight loss than some newer medicines, but it has a different mechanism and a long history of use. Its product information reports a mean difference in weight loss of 3.2 kg compared with placebo after one year in pooled studies.

Orforglipron: In the ATTAIN-1 trial, the highest-dose group achieved an average weight reduction of about 12.4% at 72 weeks. This is a trial result, not a guarantee of what an individual patient will lose.

Getting weight loss tablets in the UK

Licensed weight loss tablets are a form of weight loss treatment supplied either on prescription after a clinical assessment, or in one case from a registered pharmacy after a pharmacist's suitability check, depending on the weight loss treatments offered through each route. There is no legitimate route that involves neither.

What are the eligibility criteria?

For the prescription tablets, the licensed criteria are broadly a body mass index (BMI) of 30 or above, or 27 to 29.9 alongside at least one weight related health condition or weight related health problems such as high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower thresholds may apply for some ethnic backgrounds, where health risk rises at a lower BMI.

Meeting a threshold is a starting point, not an outcome. Eligibility is also about whether treatment may help you move toward a healthy weight and better manage excess weight, not simply whether you meet a cutoff. A prescriber reviews your medical history, current medicines and anything that makes a particular tablet unsuitable, which is why one person may be offered one option and not another.

How do I check a supplier is legitimate?

If you want to buy weight loss pills, only use a registered pharmacy that provides a proper weight loss service after safety checks, and find the pharmacy's name and address on its website, usually in the footer.

Search that name and address on the General Pharmaceutical Council register of pharmacies.

Check a UK registered prescriber reviews the consultation, and that you can contact a clinician afterwards; a legitimate provider should start with an initial consultation, not instant checkout.

Check the product you are being sold, names its active ingredient and carries a marketing authorisation.

Read the patient information leaflet before the first dose.

What actually drives the cost?

Prices for licensed tablets vary by medicine, by strength and by what the service includes. Some prices cover the medicine alone; others include the clinical assessment, prescriber review, delivery and ongoing reviews.

Because strengths often change during treatment and these are medicines for a long term condition, compare the total cost across twelve months at the strength you are likely to be using for most of that year, rather than the headline price of a first month. And treat a price far below the general market as a warning rather than a bargain, because legitimate supply chains have real costs.

Medical Disclaimer

This article is for general information and does not replace personalised medical advice. It is not a recommendation to use any specific medicine, and it does not provide dosing instructions or a dose escalation plan. Prescription only medicines should be used only under the supervision of an appropriately qualified prescriber, following a clinical assessment. Results vary between individuals. Follow the patient information leaflet supplied with your product, and if you miss a dose, follow that leaflet and never take extra to make up for it. Speak to a healthcare professional before starting any weight loss product, including supplements, particularly if you take regular medication or have an existing health condition. Report suspected side effects through the MHRA Yellow Card scheme, and seek urgent medical attention for severe or rapidly worsening symptoms.